コアメッド Company Profile

Consulting company for pharmaceutical regulatory strategy and development strategy.

Since our establishment, we have consistently upheld the principle of "quality first," providing services related to regulatory strategy and development strategy, including data evaluation for new drugs and biopharmaceuticals in CMC, non-clinical, and clinical stages. We offer face-to-face consultations with the PMDA, assistance with manufacturing and marketing authorization applications (CTD preparation), and responses to inquiries for pharmaceutical and biopharmaceutical companies both domestically and internationally, contributing to the prompt approval of new drugs. In recent years, we have also been providing services related to the development and regulatory affairs of regenerative medicine products. Please feel free to contact us if you have any inquiries.